NCT06093932

Efficacy of Songling Xuemaikang Capsules on Grade 1 Hypertension: a Randomized Controlled Trial

Efficacy of Songling Xuemaikang Capsules on Grade 1 Hypertension: a Randomized, Multicenter, Double-blind, Placebo-controlled Trial

• Status: Recruiting
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Xiyuan Hospital of China Academy of Chinese Medical Sciences · Academic / Other
• Sex: All
• Age: 35 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is: 1. To evaluate the efficacy of Songling Xuemaikang Capsules(SLXMKC) with grade 1 hypertension. 2. To reveal the potiential effects of SLXMKC on vascular function and structure of patients with grade 1 hypertension. 3. To explore the underlying mechanisms of the therapeutic effects of SLXMKC on the intervention of grade 1 hypertension.

Conditions

• Hypertension,Essential

Interventions

Type	Name	Description
DRUG	Songling Xuemaikang Capsules	3 capsules at a time, three times a day, duration: 12 weeks
BEHAVIORAL	Lifestyle intervention	everyday, duration: 12 weeks
DRUG	Placebo	3 capsules at a time, three times a day, duration: 12 weeks

Timeline

• Start date: 2024-04-07
• Primary completion: 2024-12-01
• Completion: 2027-12-01
• First posted: 2023-10-23
• Last updated: 2024-08-20

Locations

5 sites across 1 country: China